Easton Pharmaceutica Debt To Equity vs. Number Of Employees
| EAPH Stock | USD 0.0001 0.00 0.00% |
Debt To Equity | First Reported 2010-12-31 | Previous Quarter 0.32 | Current Value 0.31 | Quarterly Volatility 3.47105003 |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.14 | 0.15 |
|
|
For Easton Pharmaceutica profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Easton Pharmaceutica to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Easton Pharmaceutica utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Easton Pharmaceutica's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Easton Pharmaceutica over time as well as its relative position and ranking within its peers.
Easton |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Easton Pharmaceutica. If investors know Easton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.001 | Return On Assets (0.01) | Return On Equity (0.03) |
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Easton Pharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Easton Pharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Easton Pharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Easton Pharmaceutica Number Of Employees vs. Debt To Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Easton Pharmaceutica's current stock value. Our valuation model uses many indicators to compare Easton Pharmaceutica value to that of its competitors to determine the firm's financial worth. Easton Pharmaceutica is one of the top stocks in debt to equity category among its peers. It is currently under evaluation in number of employees category among its peers . As of now, Easton Pharmaceutica's Debt To Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Easton Pharmaceutica's earnings, one of the primary drivers of an investment's value.Easton Number Of Employees vs. Debt To Equity
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Easton Pharmaceutica |
| = | 0.43 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Easton Pharmaceutica |
| = | null |
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Easton Number Of Employees vs Competition
Easton Pharmaceutica is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 733. Easton Pharmaceutica adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Easton Pharmaceutica Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Easton Pharmaceutica, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Easton Pharmaceutica will eventually generate negative long term returns. The profitability progress is the general direction of Easton Pharmaceutica's change in net profit over the period of time. It can combine multiple indicators of Easton Pharmaceutica, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -216.8 K | -227.7 K | |
| Net Loss | -216.8 K | -227.7 K | |
| Income Before Tax | -216.8 K | -227.7 K | |
| Total Other Income Expense Net | -40.5 K | -42.5 K | |
| Net Loss | -216.8 K | -227.7 K | |
| Net Loss | -216.8 K | -227.7 K | |
| Change To Netincome | -308 K | -292.6 K | |
| Income Quality | (1.82) | (1.73) | |
| Net Income Per E B T | 1.15 | 1.11 |
Easton Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Easton Pharmaceutica. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Easton Pharmaceutica position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Easton Pharmaceutica's important profitability drivers and their relationship over time.
Use Easton Pharmaceutica in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Easton Pharmaceutica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Easton Pharmaceutica will appreciate offsetting losses from the drop in the long position's value.Easton Pharmaceutica Pair Trading
Easton Pharmaceutica Pair Trading Analysis
The ability to find closely correlated positions to Easton Pharmaceutica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Easton Pharmaceutica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Easton Pharmaceutica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Easton Pharmaceutica to buy it.
The correlation of Easton Pharmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Easton Pharmaceutica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Easton Pharmaceutica moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Easton Pharmaceutica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Easton Pharmaceutica position
In addition to having Easton Pharmaceutica in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Railroads Thematic Idea Now
Railroads
Companies involved in manufacturing and maintenance of freight railroads and passenger trains as well as providing railroad services to public. The Railroads theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Railroads Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
To fully project Easton Pharmaceutica's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Easton Pharmaceutica at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Easton Pharmaceutica's income statement, its balance sheet, and the statement of cash flows.